Novel pharmacological compounds for the treatment and prevention of cataracts

New family of molecules derived from Isoquercetin for the treatment and/or prevention of inflammatory and degenerative eye diseases.

Light-controlled beta blockers for the treatment of ocular diseases

Compounds useful as reversible visible-light-regulated antagonists for the localized and temporally restricted activation of beta-adrenoceptors, with…